RADIOACTIVE IODINE AS AN INDICATOR IN THYROID PHYSIOLOGY. IV. THE METABOLISM OF IODINE IN GRAVES' DISEASE.
作者信息
Hertz S, Roberts A, Salter W T
机构信息
Thyroid Clinic of the Massachusetts General Hospital, Boston.
出版信息
J Clin Invest. 1942 Jan;21(1):25-9. doi: 10.1172/JCI101275.
Abstract
摘要
相似文献
1
RADIOACTIVE IODINE AS AN INDICATOR IN THYROID PHYSIOLOGY. IV. THE METABOLISM OF IODINE IN GRAVES' DISEASE.放射性碘作为甲状腺生理学指标。IV. 格雷夫斯病中碘的代谢
J Clin Invest. 1942 Jan;21(1):25-9. doi: 10.1172/JCI101275.
2
Histologic Findings and Cytological Alterations in Thyroid Nodules After Radioactive Iodine Treatment for Graves' Disease: A Diagnostic Dilemma.Graves病放射性碘治疗后甲状腺结节的组织学表现及细胞学改变：诊断难题
Int J Surg Pathol. 2017 Jun;25(4):314-318. doi: 10.1177/1066896917693091. Epub 2017 Feb 15.
3
Enhanced thyroid iodine metabolism in patients with triiodothyronine-predominant Graves' disease.以三碘甲状腺原氨酸为主的格雷夫斯病患者甲状腺碘代谢增强。
J Clin Endocrinol Metab. 1988 Jan;66(1):147-52. doi: 10.1210/jcem-66-1-147.
4
Radioactive iodine in the study of thyroid physiology; the use of radioactive iodine therapy in Graves' disease.放射性碘在甲状腺生理学研究中的应用；放射性碘疗法在格雷夫斯病中的应用。
West J Surg Obstet Gynecol. 1946 Dec;54(12):474-86.
5
RADIOACTIVE IODINE AS AN INDICATOR IN THYROID PHYSIOLOGY. V. THE USE OF RADIOACTIVE IODINE IN THE DIFFERENTIAL DIAGNOSIS OF TWO TYPES OF GRAVES' DISEASE.放射性碘作为甲状腺生理学的一种指示剂。五、放射性碘在两种格雷夫斯病鉴别诊断中的应用
J Clin Invest. 1942 Jan;21(1):31-2. doi: 10.1172/JCI101276.
6
Quantitative measurement of thyroid blood flow for differentiation of painless thyroiditis from Graves' disease.甲状腺血流定量测量用于鉴别无痛性甲状腺炎与格雷夫斯病。
Clin Endocrinol (Oxf). 2007 Jul;67(1):41-5. doi: 10.1111/j.1365-2265.2007.02832.x. Epub 2007 Apr 15.
7
Radioactive iodine therapy in Graves' hyperthyroidism: a prospective study from a tertiary referral centre in north India.放射性碘治疗格雷夫斯甲亢：来自印度北部一家三级转诊中心的前瞻性研究。
J Assoc Physicians India. 2005 Jul;53:603-6.
8
[The relationship between serum thyroid autoantibodies, iodine intake, development and prognosis of Graves' disease].[血清甲状腺自身抗体、碘摄入量与Graves病的发生发展及预后的关系]
Zhonghua Nei Ke Za Zhi. 2006 Feb;45(2):95-9.
9
Successful Management of Patients with Co-existent Graves' Disease and Autoimmune Hepatitis.并存格雷夫斯病和自身免疫性肝炎患者的成功管理
Cureus. 2019 May 11;11(5):e4647. doi: 10.7759/cureus.4647.
10
Relapse of Graves' disease 23 years after treatment with radioactive iodine (131I).放射性碘（131I）治疗23年后格雷夫斯病复发。
J Clin Lab Immunol. 1985 Oct;18(2):103-5.
引用本文的文献
1
Early proteomic response in thyroid gland after 131I administration in female Balb/c mice.雌性Balb/c小鼠给予131I后甲状腺的早期蛋白质组学反应。
Radiat Prot Dosimetry. 2025 Aug 26;201(13-14):887-898. doi: 10.1093/rpd/ncaf057.
2
The evolution and hotspots of radioactive iodine therapy in hyperthyroidism: a bibliometric analysis.甲状腺功能亢进症放射性碘治疗的进展与热点：一项文献计量分析
Nucl Med Commun. 2025 Mar 1;46(3):204-217. doi: 10.1097/MNM.0000000000001940. Epub 2024 Dec 6.
3
Molecular Perspectives in Radioactive Iodine Theranostics: Current Redifferentiation Protocols for Mis-Differentiated Thyroid Cancer.放射性碘诊疗学的分子视角：分化型甲状腺癌的当前再分化方案
J Clin Med. 2024 Jun 21;13(13):3645. doi: 10.3390/jcm13133645.
4
Correlation between the thyroid computed tomography value and thyroid function in hyperthyroidism: a retrospective study.甲状腺 CT 值与甲亢患者甲状腺功能的相关性：一项回顾性研究。
Ann Nucl Med. 2024 Aug;38(8):659-665. doi: 10.1007/s12149-024-01938-0. Epub 2024 May 24.
5
The influence of thionamides on intra-thyroidal uptake of I during radioiodine-131 treatment of Graves' disease.硫脲类药物对 131I 治疗格雷夫斯病时甲状腺内摄取碘的影响。
Sci Rep. 2023 Dec 1;13(1):21190. doi: 10.1038/s41598-023-47228-z.
6
The influence of thyroid hormone medication on intra-therapeutic half-life of I during radioiodine therapy of solitary toxic thyroid nodules.甲状腺激素药物对孤立性毒性甲状腺结节放射性碘治疗期间 I 内治疗半衰期的影响。
Sci Rep. 2022 Aug 17;12(1):13925. doi: 10.1038/s41598-022-18170-3.
7
Radiotheranostics - Precision Medicine in Nuclear Medicine and Molecular Imaging.放射性药物治疗学——核医学与分子影像中的精准医学。
Nanotheranostics. 2022 Jan 1;6(1):103-117. doi: 10.7150/ntno.64141. eCollection 2022.
8
Advances in Functional Imaging of Differentiated Thyroid Cancer.分化型甲状腺癌的功能成像进展
Cancers (Basel). 2021 Sep 23;13(19):4748. doi: 10.3390/cancers13194748.
9
Celebrating eighty years of radionuclide therapy and the work of Saul Hertz.庆祝放射性核素治疗 80 周年和 Saul Hertz 的工作。
J Appl Clin Med Phys. 2021 Jan;22(1):4-10. doi: 10.1002/acm2.13175.
10
Focus on radioiodine-131 biokinetics: the influence of methylprednisolone on intratherapeutic effective half-life of I during radioiodine therapy of Graves' disease.关注放射性碘-131 的生物动力学：甲基强的松龙对格雷夫斯病放射性碘治疗期间 I 内治疗有效半衰期的影响。
Endocrine. 2021 Jul;73(1):125-130. doi: 10.1007/s12020-020-02593-x. Epub 2021 Jan 13.
本文引用的文献
1
Observations on the iodine-containing compounds of the thyroid gland. Isolation of dl-3:5-di-iodotyrosine.关于甲状腺含碘化合物的观察。dl-3:5-二碘酪氨酸的分离。
Biochem J. 1929;23(3):373-83. doi: 10.1042/bj0230373.
Zotero 插件